Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

In this episode of Denatured, you'll listen to Viswa Colluru, CEO and founder of Enveda and Akshay Rai, principal, Healthcare & Biotech Investments at Premji Invest. We speak about how AI platforms ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

A new drug delivery approach uses modified Listeria monocytogenes to target colorectal cancer and improve pre-clinical outcomes.

Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the ...

Karan Arora, senior vice president of advanced assays, AI, and pharma services at Leica Biosystems outlines the critical role diagnostics have to play in unlocking the promise of precision medicine.

Advancing HBV Functional Cure Toward Key Phase 2b Data ReadoutsIncreasing Discovery Efforts to Drive Long-term Value CreationStrong Cash Position ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...

The new alliance has launched a multi-agent AI framework to support faster, data-driven decisions in cancer research. Agentic AI system achieves 15x faster insights with over 90% accuracy.

Cells face constant threats from inside and out. Thus, they’ve evolved sophisticated stress response pathways such as the unfolded protein response (UPR), ...

AI platform integrates academic and defense research to accelerate rapid antidote discovery and federal stockpiling for emerging chemical threats. SACRAMENTO, Calif., March 19, 2026 /PRNewswire/ -- ...

Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of p53-based ...